FDA approves first non-opioid pain reliever in over 20 years

For the first time in decades, a new type of acute pain medication that is not an opioid has been approved in the USA.

Jazz anklagas för falskspel – går med på förlikning

Irländska Jazz Pharmaceuticals har gått med på att betala 145 miljoner dollar i förlikning efter anklagelser om brott mot amerikanska konkurrenslagar.

Novo Nordisk to invest billions in new quality control lab

Novo Nordisk has announced plans to invest 2.9 billion Danish kroner in order to establish a new quality control laboratory in Hillerød in northern Zealand, Denmark.

The business coach: “We need to learn from our mistakes”

The past year has been challenging for many biotech companies, with several comapanies facing financial stress and bankruptcy. To understand how entrepreneurs c...

Europeiska läkemedelsaktier rasar efter Trumps tullhot

Europeiska läkemedelsbolag faller kraftigt efter att USA:s president Donald Trump flaggat för att stora tullhöjningar är på gång mot branschen.

Norway rejects national life science strategy – sees no need

The Norwegian Arbeiderpartiet rejects a proposal that Norway should develop its own life science strategy.

New Updates in Drug Formulation & Bioavailability 2026

He takes over the chairmanship of Karolinska Development

Ben Toogood is appointed as the new chairman of Karolinska Developments.

Career coach on salaries: “There is no right or wrong”

What is a reasonable salary for my job? It's a question we all ask ourselves. But how important is a higher salary really? Career coach Tina Persson believes th...

The future of healthcare in focus: ”Together, things happen”

In march, it’s once again time for Fokus Patient, an event for the industry where the patients’ perspective takes center stage. It’s a great way to spread knowl...

Explore our tailored program for Control 2025

Choose an innovation tour, or join our industry-specific guided tours.

Europeiska läkemedelsaktier faller inför Trumps tullbesked

Flera bolag inom den europeiska läkemedelssektorn sjunker på börsen inför kvällens tullbesked från USA.

Bioscience – Groundbreaking Research & Diagnostics: Stockholm

Tau-targeted Alzheimer's drug gets Fast Track designation in the USA

Biogen's Alzheimer's candidate BIIB080 has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA).

Misslyckande för BMS i sen studie om hjärtläkemedel

Läkemedelsjätten Bristol Myers Squibbs läkemedel mot en typ av hjärtsjukdom misslyckades i en sen klinisk studie. Det svaga utfallet ökar kraven på positiva utf...

Roche överväger stoppa USA-satsning om Trump fullföljer läkemedelsplan

President Donald Trumps försök att pressa internationella företag att investera mer i USA, bland annat genom kontroversiella tullar kan få motsatt effekt. Nu öv...

New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified insulin-producing cells that do not require...

New features in ZEISS CALYPSO 2024

ZEISS CALYPSO is your universal software for dimensional metrology applications.

Unmatched performance and flexibility in its class

The new ZEISS SPECTRUM family is equipped to be the ideal match from measuring small electronics up to larger housings.

LINK Medical recruits Swedish CEO

The Norwegian Contract Research Organization LINK Medical has recruited Anders Göransson as the new CEO.

Pneumatics Makes a Technological Leap with Piezo

The first high-precision proportional valve terminal VTEP opens up new application areas

Viktor Hrvota dubblar vd-skapet – tar över Umecrine Cognition

Umecrine Cognition har utsett Viktor Drvota till ny vd efter avgående Anders Karlsson.

New Horizons in Biologics & Bioprocessing: Copenhagen 2026

Tung patentutgång får Novartis att banta personalstyrkan

Novartis planerar att kapa bort 427 tjänster i USA, bland annat till följd av en kommande patentutgång för bolagets hjärtläkemedel Entresto.